Study at a glance
What is a vitamin D population reference range?
It describes the spread of vitamin D results in a selected group of people. Its limits depend on who was studied, when samples were taken and how the laboratory measured them.
Does being inside a vitamin D reference range prove that everything is healthy?
No. A population range is a comparison tool. It does not directly measure every vitamin D function or prove that everyone inside it has the same needs. A result outside it also needs interpretation.
Is a vitamin D reference limit the same as a treatment threshold?
No. A reference limit describes a population. A clinical threshold guides a decision using evidence about health or risk. The numbers printed beside a result need to be understood according to which job they are doing.
Can two results inside the same range still differ meaningfully?
Yes. A broad population range can hide changes within one person. Timing, laboratory uncertainty and that person’s previous results help determine what a change means.
Read the full article below ↓A vitamin D population reference range can look like a simple pair of numbers printed beside a blood-test result, but those numbers sit at the end of a much larger scientific process. Investigators must define a reference population, decide who is included and excluded, obtain and measure serum 25-hydroxyvitamin D, or 25(OH)D, account for analytical performance and then apply a statistical method to describe the resulting distribution. The final interval can therefore change when the population, season, measurement method or statistical approach changes.
That matters because a population reference interval is frequently asked to do a second job for which it was not designed: determine whether one individual’s vitamin D status is physiologically sufficient, clinically important or meaningfully different from their previous result. The combined evidence shows why those are separate questions.
The central conclusion is straightforward: population ranges are useful descriptive tools, but their scientific authority depends on how they were constructed and on the question being asked of them. A range can describe where values lie in a population without defining an optimal personal target, a treatment threshold or the boundaries of healthy physiology.
A reference interval begins with a population, not a threshold
The conventional laboratory reference interval is generally intended to describe the distribution of an analyte within a selected reference population. A common construction uses the central 95 percent of observations, with the lower and upper limits corresponding approximately to the 2.5th and 97.5th percentiles.
Those endpoints are statistical properties of the selected group. They are not automatically concentrations at which physiology changes from healthy to unhealthy.
This is an important distinction because vitamin D terminology often compresses several different concepts into the language of “normal.” A population interval, a deficiency definition, a clinical decision limit, a physiological target and a treatment objective can all involve numerical 25(OH)D concentrations, but the evidence needed to establish each one is different.
The difference between descriptive limits and intended targets is explored further in Vitamin D Thresholds vs Targets.
Who enters the reference population changes the answer
Before an interval can be calculated, researchers must decide which observations belong in the reference population. That choice can materially affect the resulting distribution.
A direct reference-interval study deliberately recruits individuals judged appropriate for the population being described. Investigators may define inclusion and exclusion criteria before recruitment or apply additional exclusions after data collection. The resulting reference group is therefore constructed according to explicit biological and methodological assumptions.
For vitamin D, those assumptions matter particularly strongly. Age, latitude, sunlight exposure, season, diet, supplementation, body composition and health state can all influence circulating 25(OH)D. Two carefully conducted reference studies can therefore produce different intervals because they studied genuinely different populations rather than because one necessarily made a statistical mistake.
This helps explain why apparently conflicting vitamin D numbers need context rather than automatic reconciliation. The broader problem is addressed in Why Vitamin D Results Differ.
Direct and indirect reference intervals solve the same problem differently
The classical direct approach recruits a dedicated reference population. Once suitable participants have been identified and measured, the resulting observations can be ranked and used to estimate percentile-based reference limits without requiring a normal Gaussian distribution.
Indirect methods take another route. Instead of recruiting a new healthy cohort, they analyse large existing laboratory databases and use statistical procedures to identify the distribution most likely to represent the reference population while limiting contamination from pathological or otherwise unsuitable observations.
Indirect methods can exploit very large datasets and therefore achieve considerable statistical precision. Their challenge is different: the people in those databases were not necessarily recruited as reference volunteers. The method must infer the underlying reference distribution from real-world clinical data.
Neither method escapes population dependence. Direct approaches make population selection explicit at recruitment. Indirect approaches make it part of the statistical separation problem.
Vitamin D shows that construction method can materially change the range
A 2024 Spanish investigation directly compared both methods for serum 25(OH)D. The indirect dataset contained 7,222 observations, while the direct component recruited 312 healthy volunteers.
The resulting intervals were materially different. The indirect approach produced an interval of approximately 5.6 to 57.2 ng/mL. The directly recruited healthy population produced an interval of approximately 9.0 to 41.4 ng/mL.
The important point is not that one interval must therefore be correct and the other incorrect. The result demonstrates that “the reference range” is partly a consequence of how the reference population is defined and extracted from the data.
Season changes the population before the statistics begin
Vitamin D is unusual among many routine laboratory analytes because the population distribution can change substantially across the year. Cutaneous vitamin D synthesis varies with ultraviolet B exposure, and that produces seasonal movement in circulating 25(OH)D in many populations.
In the Spanish direct reference study, the estimated lower reference limit was around 7.4 ng/mL in winter and around 13.3 ng/mL in summer. The upper distribution also moved.
The statistical method did not create this seasonal difference. It described a population whose underlying biology had changed with season.
This is why the biological variability discussed in Biological Noise in Vitamin D Testing and the statistical construction of a reference interval cannot be separated completely. Population statistics inherit the biological variation present in the population being measured.
Measurement method can shift an entire population distribution
Reference ranges are calculated from laboratory measurements, so analytical bias can move the observed distribution before the statistical limits are calculated.
Vitamin D assay-standardisation programmes provide direct evidence of this effect. Different assays and laboratories have historically produced systematically different 25(OH)D results. Standardisation against recognised reference measurement procedures can therefore alter not only individual values but also population prevalence estimates.
In Canadian national survey data, standardisation changed the estimated proportion of participants below 50 nmol/L from 29.0 percent to 36.8 percent.
In an Irish national survey, the estimated proportion below 30 nmol/L increased from 6.5 percent using the original ELISA results to 11.4 percent after standardisation. Reanalysis by standardised LC-MS/MS produced 11.2 percent.
The biological population did not change during these recalculations. The analytical calibration changed. This is a clear example of why Variability in Vitamin D Measurements can alter the interpretation of population statistics.
A very precise range can still describe the wrong population for the question
Large datasets reduce sampling uncertainty and can produce narrow confidence intervals around statistical estimates. That does not automatically improve biological relevance.
A very large laboratory database can describe its underlying population with great numerical precision while still being poorly matched to another population, another season or a particular individual. Statistical precision and biological representativeness are different properties.
This distinction is part of the wider problem addressed in Misuse of Vitamin D Statistics: more observations can make an estimate more precise without changing what that estimate actually represents.
The individual problem begins where the population calculation ends
Once a population interval has been constructed correctly, a second question remains: how well does that interval describe meaningful change in one person?
Biological-variation research shows why the answer can be limited. Viljoen and colleagues estimated within-person variation in 25(OH)D at 12.1 percent and between-person variation at 40.3 percent.
The much larger between-person component means that a reference interval built from many people contains a wider range of values than one individual typically occupies over time.
The index of individuality makes the mismatch visible
The index of individuality compares the amount of within-person variation with the variation observed between people. For 25(OH)D, Viljoen and colleagues calculated an index of approximately 0.3.
A low index indicates that the population interval has limited sensitivity for detecting change within an individual. A person can move substantially relative to their own established pattern while remaining comfortably inside the population interval.
This does not invalidate the population range. It shows that population comparison and serial individual monitoring are different analytical tasks.
Two values inside the same range are not necessarily equivalent
If a person’s 25(OH)D changes from one measurement to another, merely checking whether both results remain inside the population interval does not establish whether the change is meaningful.
Sequential interpretation depends on biological variation within that person and on analytical variation in the measurement process. Viljoen and colleagues estimated a critical difference of approximately 38.4 percent under the conditions of their study.
That value should not be converted into a universal clinical rule, but it demonstrates the underlying principle: meaningful serial change is a different statistical problem from whether a value lies within a population interval.
The distinction is developed further in Short-Term vs Long-Term Vitamin D Status.
Season can move both the person and the population
Season creates an additional interpretive problem because it can move the individual’s concentration and the population distribution used for comparison at the same time.
A person measured near their annual high point may appear quite different from the same person measured near their annual low point. If the reference interval itself was derived from a different seasonal mixture of observations, the comparison becomes still more context-dependent.
This does not mean seasonal reference intervals are always required. It means that season is part of the evidence needed to understand what a particular population distribution represents.
Thresholds can make modest variation look categorical
A reference concentration is continuous. Clinical and public-health interpretation often converts that continuous value into categories.
A person whose measured concentration changes only slightly can therefore cross a numerical boundary and receive a different label. The categorical change may appear dramatic even when the underlying biological difference is small.
This is especially relevant when biological variation and assay uncertainty are of similar magnitude to the distance between the measured value and the threshold.
The appropriate conclusion is not that thresholds should never be used. It is that the certainty of the category cannot exceed the certainty of the measurement and the evidence supporting the threshold.
Reference intervals, sufficiency and treatment limits are not interchangeable
A reference interval is constructed from the distribution of a reference population. Vitamin D sufficiency requires a physiological or clinical interpretation. A treatment threshold requires evidence that a management decision is justified at that concentration.
Those concepts can overlap, but one cannot be derived automatically from another.
This is why Vitamin D Sufficiency Explained has a different function from a laboratory reference-range page. Statistical frequency does not itself establish biological adequacy.
The 2024 Endocrine Society guideline illustrates the distinction
The 2024 Endocrine Society guideline suggests against routine 25(OH)D testing in generally healthy adults without an established indication for testing and notes that outcome-specific 25(OH)D levels associated with benefit have not been established in clinical trials for these generally healthy populations.
That conclusion does not imply that 25(OH)D has no physiological meaning or that laboratory ranges are useless. It illustrates why describing a population distribution is not sufficient to establish that everyone should be screened or treated toward a particular numerical target.
A blood concentration is not a complete measurement of vitamin D function
Serum 25(OH)D is the established circulating marker used to assess vitamin D status, but a concentration does not directly measure every downstream process influenced by vitamin D biology.
Local activation, receptor signalling, tissue responsiveness and endocrine regulation all sit beyond the serum concentration itself. A population interval therefore describes variation in the circulating marker rather than proving that all individuals inside that interval have identical biological function.
The distinction between circulating concentration and wider biological meaning is explored in What Vitamin D Levels Represent and Functional Vitamin D Status.
Why population reference ranges remain useful
The limitations of population reference ranges should not be confused with an argument for abandoning them.
A well-constructed interval can identify values that are statistically unusual for the relevant reference population, support laboratory interpretation, reveal population patterns and provide a common descriptive framework when analytical methods are appropriately standardised.
The limitation appears when a descriptive statistical tool is assigned a stronger biological or clinical meaning than its construction supports.
A stronger interpretation framework
The combined evidence supports interpreting a vitamin D result through several distinct questions rather than asking only whether it is “inside the range.”
First, what population produced the reference interval? Second, when were those people sampled? Third, how was 25(OH)D measured and was the method appropriately standardised? Fourth, is the number being used descriptively or as a clinical decision threshold? Fifth, is the question population comparison or change within one individual?
Those questions preserve the legitimate value of population statistics while preventing the range from becoming a substitute for individual physiological interpretation.
What the combined evidence establishes
Reference intervals are constructed: their limits depend on population selection, sampling, analytical measurement and statistical methodology.
Direct and indirect methods can produce different intervals: this reflects differences in how the reference population is defined and recovered from data.
Season matters: vitamin D population distributions change across the year, so the biological population being described is not necessarily stationary.
Assay calibration matters: standardisation can alter population prevalence estimates without any biological change in the people being studied.
Population and individual variability differ: between-person variation in 25(OH)D is substantially greater than within-person variation, limiting the ability of a broad population range to describe meaningful personal change.
Reference limits are not automatically clinical limits: population percentiles, physiological sufficiency, diagnostic thresholds and treatment targets require different forms of evidence.
What the combined evidence does not establish
The evidence does not establish that population reference intervals are meaningless or that vitamin D blood testing is inherently unreliable. It does not establish one universal personal vitamin D target. It does not show that every change between sequential measurements is clinically important. It does not justify treating the lower reference limit as an automatic deficiency threshold or the upper reference limit as an automatic toxicity threshold.
Nor does it establish that every person inside the population interval is physiologically sufficient or that every person outside it requires intervention.
Final interpretation
Vitamin D population reference ranges are most useful when their statistical purpose is kept clear. They describe how measured 25(OH)D values are distributed in a defined population under defined conditions. They can provide valuable comparative context, but they do not become universal biological targets simply because they appear beside an individual laboratory result.
The stronger interpretation keeps population construction, analytical validity and individual physiology separate. The range tells us where a number sits among other measured numbers. Understanding what that number means for one person requires an additional layer of biological and clinical reasoning.
Primary sources and publication details
Horowitz GL. Reference intervals: practical aspects. eJIFCC. 2008. Read the full source.
Jones GRD, Haeckel R, Loh TP, et al. Indirect reference intervals: harnessing the power of stored laboratory data. Clinical Chemistry and Laboratory Medicine. 2019. Read the full source.
Direct and indirect reference intervals of 25-hydroxyvitamin D: it is not a real vitamin D deficiency pandemic. 2024. PMID: 38882584. Read the full study.
Viljoen A, Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. Journal of Clinical Laboratory Analysis. 2011;25(2):130-133. PMID: 21438007. Read the full study.
Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey. American Journal of Clinical Nutrition. 2015. Read the full study.
Cashman KD, Kiely M, Kinsella M, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data. American Journal of Clinical Nutrition. 2013. Read the full study.
Sempos CT, Heijboer AC, Bikle DD, et al. Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement. 2017. Read the full source.
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism. 2024;109(8):1907-1947. Read the guideline.
Related reading
Vitamin A, D, and E Levels and Reference Ranges for Pregnant Women: A Cross-Sectional Study 2017 to 2019
This study aimed to propose pregnancy-specific vitamin reference ranges and to investigate the factors influencing vitamin levels during pregnancy.
Original paper ↗Read more →How Vitamin D Population Reference Ranges Are Derived and Statistically Constructed: Full Study
Explore how vitamin D population reference ranges are constructed, including reference populations, statistical methods, season, assay standardisation and interpretation.
Read more →How Vitamin D Population Reference Ranges Are Derived and Statistically Constructed: Study Summary
A concise evidence summary explaining how vitamin D reference ranges are calculated, how populations are selected and why methods can produce different intervals.
Read more →Limits of Applying Population Vitamin D Ranges to Individual Status: Full Study
Review the limitations of applying population vitamin D ranges to individual status, including biological variation, individuality and clinical interpretation.
Read more →Chinese Bone Turnover Marker Study: Reference Ranges for C-Terminal Telopeptide of Type I Collagen and Procollagen I N-Terminal Peptide by Age and Gender
The multi-center, cross-sectional Chinese Bone Turnover Marker Study included 3800 healthy volunteers in 5 Chinese cities.
Original paper ↗Read more →Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status
In vitamin D sufficiency, median PTH was 31.9 pg/mL [range (2.5th: 97.5th percentile) 17.9 to 58.6] compared with 35.5 pg/mL (17.0 to 60.4) for insufficiency, and 39.8 pg/mL (19.5 to 86.4) for deficiency.
Original paper ↗Read more →Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement
Moreover, despite recent efforts to standardize the assay and minimize its variability, the current bias for measured vitamin D concentrations is often still above the desirable ± 10% criterion.
Original paper ↗Read more →Prevalence of Vitamin D Deficiency and Its Association With PTH and Type 1 Diabetes Mellitus (T1DM) in a Multicultural Pediatric Population in the United Arab Emirates, 2023
This is a cross‐sectional study with 102 participants aged 3 to 18 years old who were selected from Salama and Cerner patient databases at Al Jalila Children’s Specialty Hospital (Dubai Health).
Original paper ↗Read more →Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data
Clinical and preclinical studies have provided conflicting data on the postulated beneficial effects of vitamin D in patients with prostate cancer.
Original paper ↗Read more →Low PTH Levels in Adolescents With Anorexia Nervosa
The aim of this study was to investigate central measures of calcium and vitamin D metabolism in adolescents with newly diagnosed AN using age-specific reference ranges and to determine whether any significant abnormalities required further study.
Original paper ↗Read more →The weak correlation between serum vitamin levels and chronic kidney disease in hospitalized patients: a cross-sectional study
Chronic kidney disease (CKD) has become a global public health problem.
Original paper ↗Read more →Vitamin D and the metabolic-associated steatotic liver disease: type 2 diabetes axis: a scoping-narrative review of global evidence and emerging perspectives for Sub-Saharan Africa
However, randomized controlled trials yield conflicting results, likely due to heterogeneity in dosing and baseline status.
Original paper ↗Read more →Limits of Applying Population Vitamin D Ranges to Individual Status: Study Summary
A concise evidence summary explaining why population vitamin D ranges have important limitations when interpreting the status of an individual.
Read more →A reference interval study of serum 25-Hydroxyvitamin D among an African elderly population
The aim of this study was to establish the reference interval of serum 25-hydroxyvitamin D (25(OH)D) among an African elderly population.
Original paper ↗Read more →The establishment of serum 25-hydroxyvitamin D reference intervals in children aged 0 to 14 years in Zigong area, China
To establish the reference interval of serum 25-hydroxyvitamin D (25(OH)D) in apparently healthy children in Zigong, China, using an indirect method to provide a basis for proper clinical diagnosis and treatment.
Original paper ↗Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →25(OH)D Concentration in Neonates, Infants, and Toddlers From Poland: Evaluation of Trends During Years 1981 to 2011
The aim of this study was to analyse trends in serum 25-hydroxyvitamin D concentration (25(OH)D) change over the 30 years of operation of a single pediatric diagnostic unit.
Original paper ↗Read more →Associations of Serum 25(OH)D, PTH, and β-CTX Levels with All-Cause Mortality in Chinese Community-Dwelling Centenarians
Compared with 25(OH)D of ≥30 ng/mL, 25(OH)D < 30 ng/mL was associated with increased mortality (HR 1.52, 95% CI 1.24 to 1.86, p < 0.001).
Original paper ↗Read more →Non-linear association of serum 25-hydroxyvitamin D with urinary albumin excretion rate in normoalbuminuric subjects
Vitamin D deficiencies and increases in urinary albumin excretion (UAE) are both important and potentially related health problems; however, the nature of their relationship has not been established in normoalbuminuric subjects.
Original paper ↗Read more →Plasma concentrations of 25-hydroxyvitamin D among Jordanians: Effect of biological and habitual factors on vitamin D status
All participants filled a study questionnaire that covered age, sex, height, weight, diet, and dress style for females.
Original paper ↗Read more →What Vitamin D Levels Represent
Vitamin D blood levels reflect context, regulation, and physiology rather than simple sufficiency.
Read more →Original sources
Read the full source
Horowitz GL. Reference intervals: practical aspects.
Publication details
Horowitz GL. Reference intervals: practical aspects. eJIFCC. 2008. Read the full source.
Read the full source
Jones GRD, Haeckel R, Loh TP, et al.
Publication details
Jones GRD, Haeckel R, Loh TP, et al. Indirect reference intervals: harnessing the power of stored laboratory data. Clinical Chemistry and Laboratory Medicine. 2019. Read the full source.
Read the full study
Direct and indirect reference intervals of 25-hydroxyvitamin D: it is not a real vitamin D deficiency pandemic.
Publication details
Direct and indirect reference intervals of 25-hydroxyvitamin D: it is not a real vitamin D deficiency pandemic. 2024. PMID: 38882584. Read the full study.
Read the full study
Viljoen A, Singh DK, Farrington K, Twomey PJ.
Publication details
Viljoen A, Singh DK, Farrington K, Twomey PJ. Analytical quality goals for 25-vitamin D based on biological variation. Journal of Clinical Laboratory Analysis. 2011;25(2):130-133. PMID: 21438007. Read the full study.
Read the full study
Sarafin K, Durazo-Arvizu R, Tian L, et al.
Publication details
Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey. American Journal of Clinical Nutrition. 2015. Read the full study.
Read the full study
Cashman KD, Kiely M, Kinsella M, et al.
Publication details
Cashman KD, Kiely M, Kinsella M, et al. Evaluation of Vitamin D Standardization Program protocols for standardizing serum 25-hydroxyvitamin D data. American Journal of Clinical Nutrition. 2013. Read the full study.
Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement
Moreover, despite recent efforts to standardize the assay and minimize its variability, the current bias for measured vitamin D concentrations is often still above the desirable ± 10% criterion.
Publication details
Sempos CT, Heijboer AC, Bikle DD, et al. Concerning the vitamin D reference range: pre-analytical and analytical variability of vitamin D measurement. 2017. Read the full source.
Read the guideline
Demay MB, Pittas AG, Bikle DD, et al.
Publication details
Demay MB, Pittas AG, Bikle DD, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism. 2024;109(8):1907-1947. Read the guideline.